Global  

Study: COVID-19 Pandemic Is Slowing Down Lung Cancer Treatment For 60% Of Patients

Video Credit: Wochit News - Duration: 00:34s - Published
Study: COVID-19 Pandemic Is Slowing Down Lung Cancer Treatment For 60% Of Patients

Study: COVID-19 Pandemic Is Slowing Down Lung Cancer Treatment For 60% Of Patients

The COVID-19 pandemic has disrupted work, school, and social life around the world.

And that's not all.

According to UPI, a new study shows the novel coronavirus pandemic has caused delays in treatment for nearly 60% of lung cancer patients.

For some patients, the data showed treatment delays incurred between March 2 and May 30 lasted a month or more.

At a major health system in Canada, Just under 40% of lung cancer patients saw delays or discontinuation of "palliative chemotherapy.


You Might Like


💡 One News Page Knowledge: Other News Mentions

COVID-19 pandemic COVID-19 pandemic Ongoing pandemic of coronavirus disease 2019


United Press International United Press International International news agency

New Test Identifies Patients At Risk For Severe COVID-19 [Video]

New Test Identifies Patients At Risk For Severe COVID-19

Researchers in Ireland say they have developed a system that can predict who will suffer from severe COVID-19. According to UPI, the team of researchers revealed their study and findings on Wednesday. The scoring system, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions. Physicians will be able to identify patients who may benefit from steroids and other treatments after being infected.

Credit: Wochit News    Duration: 00:31Published
COVID-19 Patients Produce 'High-Quality' Antibodies [Video]

COVID-19 Patients Produce 'High-Quality' Antibodies

UPI reports people sickened with COVID-19 produce "high-quality" antibodies. The antibodies work against the virus five to seven months after they become infected. The findings suggest those infected with COVID-19 potentially can develop a long-lasting immunity to it. Antibodies are proteins produced by the human immune system to help the body fight off viruses. Many concerns have been expressed about immunity against COVID-19 not lasting.

Credit: Wochit News    Duration: 00:36Published
Rapid Bedside COVID-19 Test Gives Results In Two Hours, Not Twenty [Video]

Rapid Bedside COVID-19 Test Gives Results In Two Hours, Not Twenty

A new, rapid, bedside test for COVID-19 delivers results in less than two hours. UPI reports a new study says such a quick turnaround means appropriate treatment can start earlier for those already hospitalized because of their symptoms. The standard COVID-19 test swabs the patient's nose and uses polymerase chain reaction, or PCR, technology. It typically takes over 20 hours to produce results.

Credit: Wochit News    Duration: 00:37Published
Who's Most Likely To Break Social Distancing Guidelines? [Video]

Who's Most Likely To Break Social Distancing Guidelines?

New research from Harvard and Calgary Universities have shed new light on who is more or less likely to observe COVID-19 social distancing guidelines. UPI reports more North American and European men, and young adults of both sexes, fail to adhere to COVID-19 social distancing guidelines than older adults. The data showed 59% of male respondents said they adhered to local social distancing guidelines, while 69% of female respondents reported doing so.

Credit: Wochit News    Duration: 00:37Published
Survey: COVID-19 Persuades Many Americans To Get Seasonal Flu Jab [Video]

Survey: COVID-19 Persuades Many Americans To Get Seasonal Flu Jab

During the 2019-20 flu season, 52% of people in the US were vaccinated against the seasonal influenza. And results of a new survey by the National Foundation for Infectious Diseases are likely to have public health officials cheering. UPI reports that of the 1,000 people surveyed, 60% of people in the United States plan to be vaccinated against the flu this winter. Nearly half said they were concerned about the potential effects of the novel coronavirus COVID-19 on the seasonal bug.

Credit: Wochit News    Duration: 00:34Published

Related news from verified sources

CytoDyn selected to make oral presentation at the “Special isirv-AVG Virtual Conference on Therapeutics for COVID-19”

CytoDyn Inc (OTCQB:CYDY), which is developing its flagship drug leronlimab (PRO 140) to battle...
Proactive Investors - Published


Tweets about this


Related videos from verified sources

FDA Approves Remdesivir to Treat COVID-19 [Video]

FDA Approves Remdesivir to Treat COVID-19

US regulators have approved the use of remdesivir, an antiviral medicine, for COVID-19 treatment.

Credit: Cover Video STUDIO     Duration: 01:20Published
Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients [Video]

Tocilizumab Reduces Risk Of Death In Severe COVID-19 Patients

Treatment with the drug tocilizumab has been shown to reduce the risk of death among hospitalized patients with severe COVID-19. Tocilizumab cuts the risk of death by about 30%, according to a study..

Credit: Wochit Tech     Duration: 00:32Published
Watch: ITBP organises yoga session at Sardar Patel COVID Care Centre and Hospital in Delhi [Video]

Watch: ITBP organises yoga session at Sardar Patel COVID Care Centre and Hospital in Delhi

Indo-Tibetan Border Police (ITBP) organised yoga session at Sardar Patel COVID Care Centre and Hospital, Radha Soami Satsang Beas in Delhi's Chhatarpur on October 17. More than 7,000 patients have been..

Credit: ANI     Duration: 01:03Published